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TGF-b receptor expression and binding in rat mesangial cells:
Modulation by glucose and cyclic mechanical strain
BRUCE L. RISER, STEPHANIE LADSON-WOFFORD, ABDULKARIM SHARBA, PEDRO CORTES,
KATIE DRAKE, CHRISTOPHER J. GUERIN, JERRY YEE, MARY E. CHOI, PATRICIA R. SEGARINI,
and ROBERT G. NARINS
Department of Internal Medicine, Division of Nephrology and Department of Eye Care Services, Henry Ford Hospital, Detroit,
Michigan; Section of Nephrology, Yale University, New Haven, Connecticut; and Celtrix Pharmaceuticals, Santa Clara,
California, USA

as the amount of ligands associated with bRs I, II, and III (100
to 250%). This same treatment also increased the levels of bRI
and bRII mRNA (30 to 40%) and the immunoreactive protein
(82 and 82%, respectively), without significantly altering the
binding affinity of the receptor. A concerted or synergistic
effect of both stimuli was not evidenced.
Conclusion. These results suggest that the modulation of
TGF-b receptors may be an additional control point in mediating the glucose- and mechanical force-induced increase in ECM
deposition by MCs.

TGF-b receptor expression and binding in rat mesangial cells:
Modulation by glucose and cyclic mechanical strain.
Background. Transforming growth factor-b (TGF-b) is a
causal factor in experimental glomerulosclerosis, and it mediates the increased extracellular matrix (ECM) accumulation
that occurs in cultured mesangial cells (MCs) exposed to high
glucose concentrations and cyclic mechanical strain. This change
is associated with increased levels of TGF-b, but may also
involve alterations in receptor expression and binding.
Methods. Rat MCs cultured in media containing either 8 or
35 mm glucose were seeded into culture plates with elastincoated flexible bottoms. Thereafter, they were subjected to cyclic
stretch or static conditions and then examined for 125I-TGF-b1
binding and expression of TGF-b receptors at the gene and
protein levels.
Results. Kinetic studies showed that MCs bound TGF-b1 in
a time- and concentration-dependent manner, expressing 6800
high-affinity receptors per cell, with an apparent dissociation
constant (Kd) of 15.4 pm, while cross-linking analysis identified
three TGF-b receptors (bR) corresponding to bRI, bRII, and
bRIII of 54, 73, and 200 kDa, respectively. Immunocytochemical studies of bRI and bRII protein revealed MC expression
in a homogeneous, punctate distribution, whereas Northern analysis demonstrated the presence of the corresponding mRNAs.
Exposure to cyclic stretching significantly increased (10%) the
overall number of TGF-b receptors, whereas ligands associated
with bRs I, II, and III also increased (25 to 50%). The finding
of increased (30 to 40%) bRI and bRII transcript levels and
immunoreactive protein (163 and 59%, respectively) in the
absence of significant changes in the apparent Kd indicated that
stretch-induced binding was the result of increased receptor
synthesis and expression and not due to a change in binding
affinity. In a similar, but more dramatic fashion, exposure to
high glucose also elevated (50%) the receptor number, as well

Transforming growth factor-b (TGF-b) is a family of
cytokines that, in mammals, includes TGF-bs 1, 2, and 3.
They possess autocrine and paracrine multifunctional activities, one of which is the stimulation of extracellular
matrix (ECM) synthesis. This function, although essential
for wound healing, is also responsible for mediating fibrosis and scarring when not down-regulated at the termination of normal tissue repair [1]. Such a pathogenetic role
of TGF-b has been convincingly demonstrated in a number of experimental models of renal glomerulosclerosis
[2–4] and is likely causal in certain forms of this disorder
in humans, including that associated with diabetes [5, 6].
The factors responsible for both inducing and sustaining the increased TGF-b activity in diabetic glomerulosclerosis are now beginning to emerge. For example,
the incubation of cultured mesangial cells (MCs) in media containing increased glucose levels, simulating the
hyperglycemic environment, induces TGF-b secretion
and ECM accumulation [7–10]. In addition, inhibition of
this TGF-b activity significantly reduces the high-glucose–
mediated induction of matrix synthesis [10]. The effect
of TGF-b on MC formation of ECM is of significance
because these cells are largely responsible for the in situ
mesangial matrix synthesis and increased deposition observed in diabetic glomerulosclerosis [11, 12].
Another factor that may be important in stimulating
and maintaining high TGF-b levels is the mechanical
strain resulting from altered glomerular hemodynamics.

Key words: cell elasticity, transforming growth factor-b, extracellular
matrix, fibrosis, scarring, tissue repair, glomerulosclerosis, diabetic kidney disease.
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Simulating in tissue culture the effects of increased glomerular distention, we have shown that cyclic cell stretching of MCs induces both increased production and activity of TGF-b1 [13], as well as synthesis and accumulation
of mesangial matrix components [14]. This stimulation
of TGF-b1 activity is manifested as an increase in mRNA
levels, secretion of protein, and the activation of the
latent molecule. Furthermore, the response is specific
for this cytokine because the activities of tumor necrosis
factor-a (TNF-a), interleukin-1 (IL-1), and even TGF-b2
remain unchanged [13]. We have also shown that the
induction of TGF-b1 activity and collagen accumulation
by stretch is further enhanced in the presence of increased glucose concentrations [15]. Finally, the marked
increase in collagen accumulation that occurs under
these conditions is reversed by the action of a TGF-b–
neutralizing antibody [15].
An important factor in the cascade of events leading
to augmented ECM production may also be changes in
TGF-b receptors. TGF-b1 and TGF-b3 mediate their
activity by binding to the TGF-b type II receptor (bRII),
a constitutively active transmembrane serine/threonine
kinase [16]. This receptor recruits and then phosphorylates another transmembrane kinase, the TGF-b receptor bRI [17], resulting in ternary complex formation and
signaling. The TGF-b type III receptor (bRIII) betaglycan is a membrane protein that increases the binding of
TGF-bs 1 and 3 to the signaling receptors and may be
necessary for equivalent TGF-b2 binding [18]. Changes
in expression and/or binding of one or more of these
receptors could then conceivably alter the biological response, irrespective of changes in the quantity of available active TGF-b.
Although little is currently known about the regulation
of TGF-b binding, it has been demonstrated that cell
density [19], as well as exposure to adrenocorticotropic
hormone [20], interferon-g [21], prostaglandin E2 [22],
or exogenous TGF-b [23]. can result in altered TGF-b
binding in certain cell types. In the rodent kidney, there
is an up-regulation in mRNA levels of bRII following
the induction of diabetes with streptozotocin [24] and of
bRII and bRIII message levels in adriamycin-induced
nephrosclerosis [25]. However, the regulation of TGF-b
binding in cultured MCs has not been examined. We
have previously reported that in cultures of MCs exposed
to a gradient of stretching amplitude, only those cells
subjected to significant mechanical strain demonstrate
intense immunostaining for the active form of TGF-b,
as opposed to those in the same culture experiencing
little or no strain [13]. This differential localization of
active TGF-b occurs even though the conditioned media
bathing all cells contains greatly increased amounts of
this factor, as compared with unstretched control cultures. This suggests the possibility that TGF-b binding
is increased in response to cyclic strain. This study was
therefore carried out to determine the effects of expo-
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sure to high-glucose medium and/or mechanical strain
on TGF-b receptor expression and binding.
METHODS
Mesangial cells
Cells, which we previously characterized and described
[26], were obtained from a cloned line derived from
outgrowths of Fischer rat glomeruli. These cells continue,
with serial passage, to express markers of MCs, including
characteristic morphology, ability to grow in media containing D-valine, and growth inhibition in the presence
of heparin or mitomycin. They additionally express the
Thy-1 antigen and demonstrate the same high sensitivity
to phorbol-stimulated neutrophil adhesion and lysis as
do early passage MCs, indicating continued expression
of essential cell surface receptors [27]. Stock cultures
were propagated in the growth medium RPMI 1640,
containing antibiotics, 20% Nu-Serum (Collaborative
Research, Bedford, MA, USA), and 8 mm glucose.
Tissue culture
Mesangial cells were seeded (5 3 104 cells/25 mm diameter well) into six-well plates with flexible elastincoated bottoms (Flex I plates; Flexcell International, McKeesport, PA, USA) and cultured in 1 ml/well of growth
medium. After either 24 or 48 hours of incubation, experimental cultures were subjected to cyclic stretching, and
the control cultures were maintained in a static environment under identical conditions. During this final period,
cells were maintained in medium containing 1% fetal
calf serum (FCS). Stretch was mediated by controlled
cycles of vacuum applied to the underside of the flexiblebottom culture well, using a computer-assisted system
(Flexercell Strain Unitt; Flexcell International). This
system provides precisely timed, negative pressure cycles
of known magnitude, deforming the bottom of the culture
well and stretching the cells attached to its surface. In
an attempt to mimic conditions of MC stretch during
possible low-frequency oscillations in intraglomerular
pressure [28], all experiments were carried out using
alternating cycles of 10-second stretch and 10-second
relaxation (50 mHz). Vacuum intensity was set to provide an average elongation of approximately 8% over
the entire culture surface [29]. Under these mechanical
conditions, cellular proliferation was unaffected.
In experiments in which the effect of high glucose concentration was studied, cells that had been maintained
in medium containing 8 mm glucose were dispersed and
then cultured for seven to eight days in the presence
of either 8 or 35 mm glucose. Cells were subsequently
dispersed and reseeded in equal densities on Flex I plates
and cultures continued in the same 8 or 35 mm glucose
media for an additional two to four days. Although 8 mm
glucose is higher than “normal physiological” levels
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(5 mm), it is substantially lower than those found in usual
culture media (11 mm) and is the minimal concentration
required for long-term growth of these cells.
Analysis of mRNA
RNA was isolated by a modified guanidinium method
in RNA Stat-60 reagent (Tel-Test Inc., Friendswood,
TX, USA). Samples were denatured in glyoxal/dimethylsulfoxide (DMSO) at 558C for 60 minutes and 20 mg of
total RNA electrophoresed on 10 mm sodium phosphate/
1% agarose gels. Gels were then stained with ethidium
bromide (5 ml/ml) and photographed, and the separated
RNAs were transferred to Genescreen membranes (NEN
Research, DuPont Co., Boston, MA, USA) by capillary
action using standard methods [30]. The blots were hybridized and probed for individual TGF-b receptor mRNAs
using the corresponding cDNAs that were 32P-labeled
by random hexamer priming (Sigma Prime-1 kit; Sigma
Chemical Co., St. Louis, MO, USA). Autoradiograms
were digitized by scanning densitometry (Scanmaster 31
Densitometer; Howtek, Hudson, NH, USA) and quantitated with image analysis (vs. 1.59, Twilight Clone BBS;
NIH Image, Silver Springs, MD). The assayed TGF-b
receptor mRNAs were normalized to rRNA (18S and
28S) to adjust for differences in loading. The probe for
bRI was an Xba I fragment of the rat activin receptorlike kinase 5 (ALK5) and hybridized to a 6.0 kb transcript. The bRII probe was a 2.8 kb rat full-length bRII
cDNA that hybridizes with a 5.5 kb mRNA. We produced both probes, which have both been previously
characterized [31].
Transforming growth factor-b binding assays
Transforming growth factor-b1 was iodinated using
the modified chloramine T procedure of Frolik et al
[32]. This method generated iodinated TGF-b1 with high
specific activity (100 to 150 mCi/mg) that retained its
ability to interact with the cell. All assays were performed
within two weeks of iodination. Binding assays were
performed when cells were 90 to 95% confluent, approximately 4 days after seeding. The medium was aspirated,
and cultures were incubated for two minutes at 48C in
a 20 mm glycine buffer (pH 3) containing 135 mm NaCl
to remove endogenous TGF-b. After two rinses with
binding buffer [Dulbecco’s modified Eagle’s medium
(DMEM), 25 mm HEPES, 1% bovine serum albumin
(BSA)], 125I-labeled TGF-b1 was added to the buffer to
achieve final concentrations ranging from 2 to 200 pm.
Nonspecific binding was determined in wells containing
100-fold or greater excess of unlabeled TGF-b1. Following incubation at 228C with gentle rotation, the medium
was removed for determination of free radioactivity. The
cells were then quickly washed twice with binding buffer
and with 1% Triton X-100, containing 10% glycerol,
20 mm HEPES, and 0.01% BSA. Triplicate samples were

solubilized, and the suspension was counted. Specific
TGF-b binding was determined from bound versus free
radioactivity after subtracting the amount of nonspecifically bound ligand. Specific binding accounted for 60 to
70% of the total bound radioactivity.
Cross-linking was used to determine specific binding
to TGF-b receptor isoforms. In this case, assays were
performed as described earlier in this article, except that
wells were incubated with 100 pm radiolabeled or radiolabeled plus unlabeled TGF-b1 (10 mm). Following a
two-hour incubation at 48C, the medium was removed,
and the bound ligand was cross-linked to receptors by
adding cold binding buffer containing 30 mm disuccinimidyl suberate (DSS; Pierce Chemical Co., Rockford, IL,
USA) freshly dissolved in DMSO. The samples were then
incubated at 48C for 15 minutes with gentle rocking, and
the reaction was terminated by three washes with a solution of 250 mm sucrose, 10 mm Tris, and 1 mm ethylenediaminetetraacetic acid (EDTA) to quench the remaining
cross-linker. Cells and matrix were then solubilized by
the addition of lysis buffer (as described), containing protease inhibitors phenylmethylsulfonyl fluoride (PMSF)
1 mm, Nahrungs Einheit Milch (NEM; milk nutritional
unit) 40 mm, and EDTA 1 mm. Samples were centrifuged
at 13,000 3 g for two minutes, and supernatants were
collected and boiled for two minutes in 1 3 Laemmli
buffer [33]. Lysate volumes were adjusted for protein
content and then electrophoresed on 4 to 10% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDSPAGE) gels and autoradiographed. Band intensities were
determined by scanning densitometry, as described earlier here.
Immunocytochemistry for transforming growth
factor-b receptors
Mesangial cells cultured on elastin-coated bottoms
Flex I plates were removed from 378C and washed using
an infinite dilution protocol. In brief, approximately one
half of the culture media were removed from each well,
and an equivalent amount of phosphate-buffered saline
(PBS) at 378C was added. This procedure was repeated
several times until all traces of media were removed. In
the same manner, half of the PBS was removed and
replaced with 378C, 4% (wt/vol) paraformaldehyde in
0.1 m Na Cacodylate buffer, pH 7.4 (both Sigma), again
using multiple changes, after which cells were fixed for
30 minutes at room temperature. Samples were then
washed with PBT (PBS plus 0.1% Triton X-100) to promote internalization of antibodies. Cells were blocked
with diluted goat serum (1:200) and incubated with primary antibodies diluted 1:100 in PBT with 0.5% BSA
overnight at 48C with gentle rocking. Cells were again
washed with PBT and incubated overnight at 48C in
goat ant-rabbit IgG conjugated to Cy3 (Amersham Life
Sciences, Arlington Heights, IL, USA) diluted 1:200 in
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PBS containing 0.5% BSA. After washing, MCs were
covered with 5% N-propyl gallate in glycerol, and cover
slips were applied. Cells were viewed with a BioRad 1024
(Bio-Rad, Hercules, CA, USA) laser scanning confocal
microscope. Digitized 8-bit images from representative
areas of the culture membrane were obtained under
identical conditions of laser intensity and gain and were
a composite of the fluorescent signal from 0.5 mm serial
sections. The images from each culture were divided
into quadrants and separately analyzed under identical
density calibration, and the quantity of fluorescence was
determined using image analysis (NIH Image), as we
have previously described [13]. Negative controls consisted of replacement of the primary antibody with nonimmune rabbit IgG and preincubation of the antibodies
with a 10 m excess of peptide antigen. All controls were
without detectable immunostaining. Antibodies to bRI
were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). The bRI antibody (cat. no. SC 399)
was raised against a peptide corresponding to amino
acids 482 to 501 mapping at the carboxy terminus of the
bRI (also designated ALK-5) of human origin and which
is homologous to the corresponding rat primary sequence.
Antibody to bRII (cat. no. SC 220; Santa Cruz Biotechnology) was raised against a peptide corresponding to amino
acids 550 to 565 mapping within the carboxy terminus
of the precursor form of human bRII that differs from
the corresponding rat sequence by a single residue. These
antibodies show no cross-reactivity on Western blots.
Statistical analysis
Data were expressed as means 6 sem. Unless otherwise
noted, differences between two groups were evaluated
using paired Student’s t-test. In the case in which results
in these groups were normalized according to the control
value (100%), the data were analyzed using a one-sample
t-test with a hypothesized mean of 100% to compare the
test group with the control. A paired two-sample t-test
was used to examine differences between the three test
groups. In both cases, a Holm’s test was then applied
post hoc to adjust for multiple comparisons [34].
RESULTS
TGF-b1 binding kinetics and the effect of glucose
concentration or cyclic strain
We first examined the effect of time on 125I-TGF-b1
binding in control, 8 mm glucose-incubated MCs. Specific
binding was time dependent, reaching a maximum after
120 minutes at 228C (Fig. 1). Therefore, subsequent studies were carried out using a 120-minute binding period.
Next, MCs cultured in 8 or 35 mm glucose-containing
media were examined for binding characteristics with increasing concentrations of 125I-TGF-b1. Binding occurred
in a concentration-dependent manner over the range of
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Fig. 1. Time course of 125I-TGF-b1 binding to mesangial cells (MCs).
The values represent the average of specifically bound transforming
growth factor-b1 (TGF-b1) at each time point, based on triplicate wells
in a single experiment. All values were within 10% of the average values.

1 to 35 pm (free molecule) and was saturable (Fig. 2).
High-glucose treatment increased the amount of TGF-b1
that was specifically bound. A Scatchard analysis of data
(Fig. 2, insert) indicated that a single class of high-affinity
binding sites was responsible for the binding and that
high-glucose exposure increased the amount of TGF-b1
bound at saturation, but did not alter the slope of the
binding curve [35]. Analysis of data from six separate
experiments yielded 6755 6 1465 high-affinity receptors
per cell, with an apparent dissociation constant (Kd) of
15.4 6 1.74 pm under normal glucose conditions. The
number of receptors per cell increased 50% to 10,178 6
2418 (N 5 6, P 5 0.03) following exposure to high glucose. There was, however, no significant change in the
binding affinity (8 mm, 15.4 6 1.74; 35 mm, 25.1 6 5.1,
N 5 6, P 5 0.06). The observed change was not due to
an osmolar effect. In separate experiments performed
under identical conditions, the receptor number and apparent Kd of MCs incubated in medium containing 5 mm
glucose plus 30 mm mannitol were not different from
those incubated in 5 mm glucose alone (93.1 6 8.6% and
96.4 6 11.5%, respectively, of control, N 5 4, P . 0.5).
In addition, the increase in receptor number was not
the result of a high-glucose–induced change in culture
density, as the final cell number in the two groups was
not different (8 mm, 2.21 3 10 5/culture; 35 mm, 2.24 3
10 5/culture, P 5 0.84) under the culture conditions selected. In preliminary experiments, it was shown that
the long-term culture of MCs in 30 mm glucose resulted
in a reduction in cell replication and changes in receptor
expression. MCs seeded at increasing densities and studied after four days demonstrated a significant (R 5 0.729,
P 5 0.0009, N 5 17), inverse relationship between the cell
number (3500 to 21,000 receptors per cell) and number of
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Fig. 2. Concentration-dependent 125I-TGF-b1
binding and the effect of high glucose treatment. Values shown represent specific binding, that is, the difference between total binding
of 125I-TGF-b1 and binding in the presence of
100-fold excess unlabeled transforming growth
factor-b (TGF-b) and are from a representative experiment. (Inset) Scatchard plot of data.
Treatments were either 8 mm (s) or 35 mm
glucose (d).

Fig. 3. Effects of cell stretching on concentration-dependent 125I-TGF-b1 binding. The assay
was carried out as described in Figure 2, except
mesangial cells (MCs) grown in 8 mm glucose
were subjected to 48 hours of cyclic stretch or
control, static conditions. Results are from a
representative experiment. (Inset) Scatchard
plot of data. Treatments were static (s) and
stretch conditions (d).

calculated TGF-b receptors over a range of 0.5 to 3.5
cells/well.
To next determine if mechanical strain could alter
TGF-b1 binding, MCs grown in 8 mm glucose medium
were subjected to 24 hours of cyclic stretching. This treatment increased 125I-TGF-b1–specific binding (Fig. 3). The

Scatchard analysis of the data (Fig. 3, inset) indicated
that this change was due to an increase in the number
of receptors and was not attributable to altered binding
affinity. Analysis of data from four separate experiments
demonstrated a modest, but significant, 10% increase
(static, 11,007 6 1302; stretch, 12,091 6 1473, P 5 0.039)

Riser et al: Glucose, stretch, and TGF-b receptors
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equivalent in all three receptor types. Additional experiments produced similar results after 24 and 72 hours of
stretch (not shown).

Fig. 4. Electrophoretic protein gel analysis of 125I-TGF-b1 cross-linked
to mesangial cell receptors. Binding assays on mesangial cells (MCs)
grown in 8 or 35 mm glucose were performed in duplicate, and the bound
125
I-TGF-b1 was cross-linked to receptors. Cultures were incubated with
radiolabeled transforming growth factor-b1 (TGF-b1; A), or radiolabeled
plus 100-fold excess unlabeled TGF-b1 (B). A representative autoradiogram shows three specifically labeled bands observed at 65, 85, and
200 kDa, corresponding to the TGF-b types I, II, and III receptors
complexes, respectively.

in the number of receptors. This occurred in the absence
of changes in the apparent Kd (static, 5.29 6 1.9; stretch,
6.08 6 2.8, P 5 0.43) or cell number (static, 1.29 3 10 5/
culture 6 0.245; stretch, 1.24 6 0.219, P 5 0.35).
Modulation of TGF-b receptor types by high glucose
and stretch, determined by cross-linking
The kinetic studies indicated that increased binding
resulted from an up-regulation in receptor number. This
could involve one or more of the TGF-b receptor types.
To identify those receptors responsible, MCs grown in
8 or 35 mm glucose-containing media were incubated with
100 pm 125I-TGF-b1, both with and without 100-fold excess
of unlabeled TGF-b1, followed by cross-linking of the ligand to the binding molecule(s). Three specifically labeled
bands were observed at 66, 85, and 200 kDa corresponding
to the TGF-b type I, II, and III receptor complexes, respectively (Fig. 4). Each complex represents the receptor
with an attached monomer of TGF-b1 (12 kDa). Exposure to high glucose increased the amount of TGF-b1
receptor complex in all three types (Fig. 4). This binding
was specific because the addition of unlabeled TGF-b
eliminated measurable labeled TGF-b1 binding.
Next, quantitative changes in binding among these receptors, both in response to increased glucose and/or to cyclic
stretch, were investigated. The amount of 125I-TGF-b1
receptor complex in all three types was increased by
either high glucose or 48 hours of cyclic strain, but did
not demonstrate an additional increase when exposed
to both stimuli (Fig. 5). The increase mediated by stretch
was moderate (25 to 50%) as compared with that of
glucose (100 to 250%), and the observed response was

Effect of high glucose and cyclic stretching on bRI
and bRII mRNA levels
The cross-linking studies demonstrated that the enhanced binding in response to high glucose and stretch
involved multiple TGF-b receptors. To determine if this
correlated to the message levels for these receptors, MCs
grown in either 8 or 35 mm glucose-containing media and
exposed to 48 hours of cyclic stretching, or static conditions, were subjected to Northern analysis and were probed
for bRI or bRII. MCs contained transcripts for both of
these receptors (Fig. 6). High glucose, as well as mechanical strain, induced a 30 to 50% increase in the level
of bRI mRNA (Fig. 6A). As observed in cross-linking
studies, the two stimuli applied in combination failed to
produce an additive or synergistic effect. Message levels
of bRII were also increased by high glucose or stretching
with changes mirroring those of bRI (Fig. 6B).
Modulation of bRI and bRII protein expression
determined by immunocytochemistry
The results discussed earlier in this article indicated
that increased expression of multiple TGF-b receptor
types, rather than altered binding affinity, accounts for
the increase in ligand binding induced by high glucose
and stretch. If this were the case, increased quantities of
cell-associated receptor protein in response to the stimuli
should be present and might therefore be visualized by
immunofluorescent labeling. Laser confocal microscopy
showed that antibodies to bRI bound MCs, producing a
punctate, but homogeneous distribution of fluorescence
throughout the cell (Fig. 7A). High-glucose exposure
increased the overall number of antibody-labeled foci,
but did not alter their distribution (Fig. 7B). The pattern
for bRII labeling was similar but was more diffuse than
that for bRI (Fig. 7C). As was the case for bRI, bRII
staining was similarly augmented by high-glucose exposure (Fig. 7D). This effect was confirmed by quantitative
image analysis, with an 83 and 62% elevation over control in bRI and bRII labeling, respectively (Fig. 8).
Cells grown in low-glucose–containing media were
also subjected to various intervals of mechanical strain
and were then fixed and studied by immunocytochemistry. Because in this system the stretching force is not
uniform, but increases are toward the periphery of the
well, we examined cells in the same outermost zone of
culture after 0 to 96 hours of stretching. bRI expression
was substantially up-regulated by 48 hours of cyclic stretch
and then appeared to diminish with longer periods of
stretch (Fig. 9) but still remained significantly elevated
above control levels even after 96 hours. In the same
experiments, bRII labeling was also increased by 48 hours
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Fig. 5. Effect of high glucose or mechanical strain on transforming growth factor-b1 (TGF-b1) binding to specific receptors. The intensities of
bands corresponding to bRI, bRII, and bRIII from five to seven cross-linking experiments were quantitated following optical scanning. Mesangial
cells (MCs) were grown in normal or high glucose medium and were subjected to stretch ( ) or static (h) conditions. *P , 0.05 vs. static, 8 mm
control. **P , 0.05 vs. stretch, 8 mm.

Fig. 6. Northern blot analysis of mRNA for bRI and bRII after exposure to cyclic stretch and/or high-glucose medium. A single band was detected
corresponding to (A) bRI (6.0 kb) or (B) bRII (5.5 kb), shown from a representative experiment (upper panel). Quantitative image analysis of
band intensities from four (bRI) or seven (bRII) experiments (lower panel); static (h) or stretched ( ) cultures. Results shown were normalized
to the sum of 18S and 28S ribosomal RNAs. *P , 0.002 vs. static, 8 mm control.

of stretching. The magnitude of the change was lower
than for bRI, yet it remained stable over time. As with
bRI, although the intensity of staining increased with
stretching, there was no discernible change in the cellular
pattern or distribution of the immunoreactive protein
(data not shown). This induction of receptor protein
appeared primarily localized to the cells experiencing
the greatest force, because cells present in the center of
the well increased TGF-bRI staining 35% (P , 0.05) by

the end of this period, whereas RII protein in the center
of the well decreased 49% (P , 0.05) over the same time.
DISCUSSION
The primary goal of this study was to determine the
effects of high glucose and cyclic mechanical strain on
modulation of TGF-b receptor activities. First we showed
that TGF-b1 binding was time- and concentration-

Riser et al: Glucose, stretch, and TGF-b receptors

435

Fig. 7. Immunofluorescent localization of bRI and bRII protein in mesangial cells (MCs). Following growth in 8 mm (A, C) or 35 mm (B, D, E)
glucose, cells were fixed and examined by laser scanning confocal microscopy for localization of bRI (A, B) or bRII (C, D). A negative control
consisted of substitution of the primary antibody with rabbit nonimmune IgG (inset E). Representative photos are shown.

dependent with MCs expressing approximately 6750
high-affinity (apparent Kd 5 25 pm) receptors per cell
when grown to near confluency. Our findings are comparable to those of Wakefield et al, who tested a wide
variety of cell types [36], and of MacKay et al, who
examined mouse MCs [37]. The former reported a range
of 600 to 40,000 high-affinity receptors per cell, with Kd
values ranging from 1 to 60 pm, whereas the latter reported 3900 receptors per MC with a Kd of 5 pm. We

observed, as did Wakefield et al, that cell density was
an important determinant of receptor binding [36].
Therefore, our studies of receptor modulation by high
glucose and mechanical strain were run under conditions
that were established to produce equivalent final cell
densities in the control and treated groups. Our crosslinking studies demonstrated that the observed specific
binding of TGF-b was to three major proteins, corresponding to bRI, bRII, and bRIII. In addition, MCs
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Fig. 8. Effect of increased glucose on the expression of bRI and bRII
protein. Quantitative image analysis measurements were obtained from
the same set of experiments represented in Figure 7. Images used for
quantitation were constructed from all of the 0.5 mm serial sections
contained in the cell layer with fluorescent signal. Bars indicate the
mean of measurements in eight separate areas, each containing 10 to
20 cells. *P , 0.05 vs. 8 mm control.

expressed mRNAs for bRI and bRII and demonstrated
a homogenous cytoplasmic distribution of the corresponding protein as determined by immunocytochemistry. The expression of mRNA and protein for bRIII was
not examined in this study because of the scarcity of
specific reagents. Others have reported the presence, in
rat glomeruli, of two TGF-b–binding proteins equivalent
to bRII and bRIII (85 and 200 kDa) [38].
The exposure of MCs to high-glucose concentrations
for a total of 10 to 12 days increased overall specific
binding, a change caused by a 50% increase in receptor
number. Although not statistically significant, we also
observed a 63% increase in the mean apparent dissociation constant, suggesting that a simultaneous reduction
in the binding affinity cannot be totally ruled out. However, it is likely that this difference can be attributed to
the interexperimental variability in the calculated affinities. Nevertheless, protein cross-linking analysis of 125ITGF-b bound to RI, RII, and RIII indicated that, at the
concentration of ligand used, the net result is increased
binding. The finding that high-glucose treatment increased to similar levels mRNA transcripts for bRI and
bRII as well as the immunoreactive receptor proteins
indicates that the observed increase in binding may result
from elevated synthesis of the receptors.
Cyclic mechanical force also increased receptor binding, a change that was qualitatively similar to that induced

Fig. 9. Effect of cyclic stretching on the expression of bRI and bRII
protein. Mesangial cells (MCs) grown in 8 mm glucose-containing media
were subjected to static or stretch conditions for the times indicated.
Cell layers were then subjected to immunocytochemical analysis and
measurements of receptor expression determined as in as in Figure 8.
*P , 0.05 vs. static control. **P , 0.05 vs. 96 hours of stretch.

by high-glucose exposure. As was the case for glucose,
stretch also increased the amount of ligand associated
with the three receptors types and was accompanied
by a corresponding elevation of receptor mRNA and
protein. A somewhat greater induction by stretch of message and protein expression was observed for bRI, in
comparison to bRII. This difference may have been related to the period studied, because our observations of
protein expression showed a decrease in the magnitude
of induction with stretching time. By 96 hours, the degree
of elevation of bRI protein was nearly equivalent to
bRII. A differential response of these two receptors was
not observed following exposure to high-glucose concentrations. Another difference in the response to the two
stimuli was in the magnitude of the increase. The greater
induction of binding by high glucose, as compared with
stretch, may also be time dependent; however, this issue
was not examined in these studies.
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In no case was there an additive or synergistic effect
when both stimuli were applied. This finding is in contrast
to our previous observations on TGF-b production and
collagen synthesis in response to these same treatments
[13, 15]. In those studies, although stretching or highglucose exposure increased TGF-b1 secretion twofold
and the corresponding mRNA levels by 30 to 45%, the
combination of both stimuli enhanced TGF-b1 secretion
greater than fivefold. The significance of this synergistic
effect on TGF-b1 secretion was indicated by the greater
stretch-induced collagen accumulation that occurred
when high glucose was also present [13, 15]. This increase
was totally blocked by the neutralization of all mammalian forms of TGF-b with specific antibodies. In the absence of high-glucose concentrations, collagen synthesis
was increased by stretch, but due to a corresponding
increase in breakdown, collagen accumulation was not
enhanced. Taken together, these studies suggest that the
mechanisms for induction of TGF-b1 production are unlike those for induction of TGF-b receptors. It may be
that increased numbers of TGF-b1 receptors, although
important in the degree of the metabolic response to
the ligand, particularly when the amount of TGF-b is
overabundant, may not be responsible for the combined
effects of stretch and high glucose on collagen accumulation that was previously observed.
The precise mechanism(s) for the increase in TGF-b
receptor activity is not yet understood. Although it is
possible that the increase in active TGF-b, occurring as
a response to high glucose or stretch, could be a direct
modulator of TGF-b receptors, published studies suggest
that this is not likely the case [39]. For example, in human
lung carcinoma cells [36] and in rat kidney fibroblasts [32],
short-term incubation with exogenous TGF-b down-regulates, rather than increases, the number of TGF-b receptors. There are little data available concerning the
long-term effects of TGF-b on the modulation of receptor expression. However, Wakefield et al, in a comparison of 12 different human and rodent cell lines, found
no relationship between the amount of TGF-b secreted
and the number of TGF-b receptors expressed [36]. Our
findings, in this study, of an additive response to mechanical strain and high-glucose levels of increased TGF-b,
without similar additive changes in TGF-b receptors,
also support this idea. Verification of this lack of relationship between the cytokine and the expression of its receptor may be difficult, as cultured MCs produce and activate
abundant amounts of TGF-b, even in the absence of stimulation by high levels of glucose or stretching. A blockade
of TGF-b over this period would alter a large number
of cellular events, including cell replication, adhesion,
and production of matrix, which may be expected to be
associated with altered TGF-b binding.
Angiotensin II appears to stimulate ECM synthesis
through the induction of TGF-b [40] and may also be a
factor in the up-regulation TGF-b receptors. However,
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this is not a likely mechanism for the observed effects
of high glucose and stretch in this study. Although there
are rare reports of renin production in MCs [41, 42], it
is questionable whether this results in the generation of
angiotensin II in tissue culture. We have observed that
treatment of MCs with the angiotensin-converting enzyme
inhibitor ramipril failed to alter either the baseline collagen synthesis in static, control cells or the collagen production stimulated by stretch (unpublished observation).
Given our understanding that a ternary complex of
bRI, bRII, and the ligand is required for signaling, an
up-regulation of both receptors may be required for increased responsiveness [16]. However, there is evidence
suggesting otherwise. We have successfully transfected
MCs with a dominant negative mutant bRII that lacks
the cytoplasmic serine/threonine kinase domain but retains the ability to bind TGF-b. Overexpression of this
mutant bRII blocked the growth inhibitory effects of
TGF-b, but failed to block the induction of collagen type I
and fibronectin mRNA (abstract; Choi et al, J Am Soc
Nephrol 8:493A, 1997). This differential induction indicates alternative signaling pathways for different responses and suggests that increased activity of one of
the two signaling receptors may be sufficient to alter
specific responses. The function of bRIII is not clear,
but it appears to present TGF-b to bRII, which then
allows increased interaction of bRII and the ligand with
the signaling receptor [18]. The observed increase in
bRIII with high glucose or stretching suggests that it too
may be involved in the induction of ECM synthesis.
The findings from these in vitro experiments may be
relevant in vivo. Hyperglycemia is an established causal
factor in diabetic glomerulosclerosis [43, 44] and may
exert its actions, at least in part, by its direct effects on
the MCs [11]. This is supported by extensive evidence
showing that increased concentrations of glucose, similar
to those employed in this study, stimulate ECM accumulation by MCs in culture [7–9, 45]. Glomerular hypertension is a second major causal factor in glomerulosclerosis
[46, 47]. The observations made in this study using cyclic
mechanical strain in tissue culture are relevant to pathophysiological forces that occur in vivo as a result of increased glomerular pressure. Our studies on the elasticity
of isolated perfused glomeruli have demonstrated that
the degree of stretching used in these studies may be
similar to that in the glomerular mesangium during experimental diabetes [14, 44]. In normal glomeruli, effective autoregulation at the afferent arteriole protects
against exposure to significant variations in systemic
blood pressure and the resulting distention [48, 49]. However, in experimental diabetes [50] and in remnant glomeruli after extensive renal ablation [51], the loss of
autoregulation results in the transferal to the glomerular
capillaries of the large (up to 55 mm Hg) moment-tomoment variations in systemic blood pressure [52]. As

438

Riser et al: Glucose, stretch, and TGF-b receptors

calculated from our direct measurements of glomerular
compliance, these oscillations in intraglomerular pressure may result in the repeated distention and contraction of up to 7.3% of mean glomerular volume and compare with an estimated change of 0.4% under normal
circumstances [43]. To what extent the observed increased levels of TGF-b receptor expression and binding
contribute to this pathological alteration is undetermined. However, in in vivo conditions, including the
progressive sclerosis of remnant glomeruli and in diabetic glomerulosclerosis, months or years of evolution of
the disease are required for the appearance of advanced
glomerular injury. This suggests that even small changes
in TGF-b receptor expression may be, in the long term,
of pathological significance.
Work in at least two experimental models of glomerulosclerosis support our findings on receptor overexpression. Sharma et al reported that bRII mRNA levels in
mice kidney cortices increase up to fourfold following
the induction of diabetes by streptozotocin and occur
concomitantly with an increase in mRNA encoding for
TGF-b1, type IV collagen, and fibronectin [4]. They also
observed that, although administration of an antibody
that neutralizes TGF-bs 1, 2, and 3 completely blocked
the increase in TGF-b1, this treatment did not fully reverse either the diabetic-induced kidney hypertrophy or
the elevated mRNA levels for matrix genes and had no
effect on increased bRII message. Tamaki et al, in a study
on the role of TGF-b1 in adriamycin-induced progressive
focal glomerulosclerosis in the same species, observed
an increase in the mRNA levels for bRII and bRIII in
the renal cortex that paralleled changes in fibronectin,
TGF-b1, and renal histological alterations [25].
In summary, there are multiple sites for the regulation
of TGF-b action that include synthesis, secretion, and
activation of the latent molecule, binding, and signal transduction. We have previously shown that mechanical strain
and high glucose are factors that influence TGF-b1 activity by a combined mechanism, altering mRNA levels
and secretion and activation of the molecule, to promote
ECM production. The findings presented here extend
these effects to receptor modulation and suggest that
effective therapy to mitigate the effects of TGF-b1 action
in diabetic kidney disease may require intervention at
multiple levels, or alternatively, downstream of TGF-b
binding.
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